Johnson Investment Counsel Inc. Sells 2,894 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Johnson Investment Counsel Inc. lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 13.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 18,643 shares of the pharmacy operator’s stock after selling 2,894 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in Walgreens Boots Alliance were worth $487,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in Walgreens Boots Alliance by 14.5% during the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock worth $1,927,656,000 after purchasing an additional 10,962,030 shares during the period. Invesco Ltd. boosted its holdings in shares of Walgreens Boots Alliance by 21.5% during the 3rd quarter. Invesco Ltd. now owns 17,026,420 shares of the pharmacy operator’s stock worth $378,668,000 after buying an additional 3,013,807 shares during the period. Morgan Stanley grew its stake in Walgreens Boots Alliance by 15.8% in the 3rd quarter. Morgan Stanley now owns 12,584,371 shares of the pharmacy operator’s stock valued at $279,876,000 after buying an additional 1,720,228 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its position in Walgreens Boots Alliance by 10.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 6,519,845 shares of the pharmacy operator’s stock worth $170,233,000 after acquiring an additional 613,847 shares during the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in Walgreens Boots Alliance by 12.4% during the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,077,336 shares of the pharmacy operator’s stock valued at $80,349,000 after acquiring an additional 339,143 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now directly owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CFO Manmohan Mahajan bought 6,000 shares of the company’s stock in a transaction on Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Trading Up 5.4 %

Shares of WBA opened at $18.12 on Tuesday. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The stock has a market cap of $15.63 billion, a PE ratio of -2.59, a PEG ratio of 1.07 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a 1 year low of $17.12 and a 1 year high of $32.89. The stock has a 50 day simple moving average of $19.19 and a 200-day simple moving average of $21.43.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the company posted $1.16 earnings per share. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 5.52%. The ex-dividend date is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research note on Monday, April 1st. Deutsche Bank Aktiengesellschaft cut their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a report on Wednesday, April 3rd. UBS Group reduced their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, April 3rd. Leerink Partnrs reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Finally, TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $24.36.

Check Out Our Latest Stock Analysis on WBA

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.